{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:14:57Z","timestamp":1790867697749,"version":"4.1.0"},"reference-count":59,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2023.0034","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T08:09:23Z","timestamp":1680077363000},"source":"Crossref","is-referenced-by-count":9,"title":["Sedation in palliative care\u2014a clinically oriented overview of guidelines and treatment recommendations"],"prefix":"10.3238","author":[{"given":"Carsten","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Ostgathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Ansgar","family":"Schildmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"10.3238\/arztebl.m2023.0034_ref1","doi-asserted-by":"crossref","unstructured":"Surges SM, Garralda E, Jaspers B, et al.: Review of European guidelines on palliative sedation: a foundation for the updating of the European Association for Palliative Care Framework. J Palliat Med 2022; 25: 1721\u201331.","DOI":"10.1089\/jpm.2021.0646"},{"key":"10.3238\/arztebl.m2023.0034_ref2","unstructured":"Forschungsverbund SedPall, Deutsche Gesellschaft f\u00fcr Palliativmedizin e.V. (eds.): Handlungsempfehlung Einsatz sedierender Medikamente in der spezialisierten Palliativversorgung. Berlin 2021. www.dgpalliativmedizin.de\/images\/210422_Broschu%CC%88re_SedPall_Gesamt.pdf (last accessed on 4 January 2023)."},{"key":"10.3238\/arztebl.m2023.0034_ref3","doi-asserted-by":"crossref","unstructured":"Schur S, Weixler D, Gabl C, et al.: Sedation at the end of life\u2014a nation-wide study in palliative care units in Austria. BMC Palliat Care 2016; 15: 50.","DOI":"10.1186\/s12904-016-0121-8"},{"key":"10.3238\/arztebl.m2023.0034_ref4","doi-asserted-by":"crossref","unstructured":"Stiel S, Nurnus M, Ostgathe C, Klein C: Palliative sedation in Germany: factors and treatment practices associated with different sedation rate estimates in palliative and hospice care services. BMC Palliat Care 2018; 17: 48.","DOI":"10.1186\/s12904-018-0303-7"},{"key":"10.3238\/arztebl.m2023.0034_ref5","doi-asserted-by":"crossref","unstructured":"Schildmann E, P\u00f6rnbacher S, Kalies H, Bausewein C: \u2018Palliative sedation\u2019? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit. Palliat Med 2018; 32: 1189\u201397.","DOI":"10.1177\/0269216318764095"},{"key":"10.3238\/arztebl.m2023.0034_ref6","doi-asserted-by":"crossref","unstructured":"Twycross R: Reflections on palliative sedation. Palliat Care 2019; 12: 1\u201316.","DOI":"10.1177\/1178224218823511"},{"key":"10.3238\/arztebl.m2023.0034_ref7","doi-asserted-by":"crossref","unstructured":"Sulmasy DP: The last low whispers of our dead: when is it ethically justifiable to render a patient unconscious until death? Theor Med Bioeth 2018; 39: 233\u201363.","DOI":"10.1007\/s11017-018-9459-7"},{"key":"10.3238\/arztebl.m2023.0034_ref8","doi-asserted-by":"crossref","unstructured":"Abarshi E, Rietjens J, Robijn L, et al.: International variations in clinical practice guidelines for palliative sedation: a systematic review. BMJ Support Palliat Care 2017; 7: 223\u20139.","DOI":"10.1136\/bmjspcare-2016-001159"},{"key":"10.3238\/arztebl.m2023.0034_ref9","doi-asserted-by":"crossref","unstructured":"Schildmann E, Schildmann J: Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision making. J Palliat Med 2014; 17: 601\u201311.","DOI":"10.1089\/jpm.2013.0511"},{"key":"10.3238\/arztebl.m2023.0034_ref10","doi-asserted-by":"crossref","unstructured":"Cherny NI, Radbruch L: European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009; 23: 581\u201393.","DOI":"10.1177\/0269216309107024"},{"key":"10.3238\/arztebl.m2023.0034_ref11","doi-asserted-by":"crossref","unstructured":"Alt-Epping B, Sitte T, Nauck F, Radbruch L: Sedierung in der Palliativmedizin*: Leitlinie f\u00fcr den Einsatz sedierender Ma\u00dfnahmen in der Palliativversorgung. Schmerz 2010; 24: 342\u201354.","DOI":"10.1007\/s00482-010-0948-5"},{"key":"10.3238\/arztebl.m2023.0034_ref12","doi-asserted-by":"crossref","unstructured":"Abarshi E, Rietjens J, Robijn L, et al.: International variations in clinical practice guidelines for palliative sedation: a systematic review. BMJ Support Palliat Care 2017; 7: 223\u20139.","DOI":"10.1136\/bmjspcare-2016-001159"},{"key":"10.3238\/arztebl.m2023.0034_ref13","doi-asserted-by":"crossref","unstructured":"Brouwers MC, Kerkvliet K, Spithoff K: AGREE Next Steps Consortium: the AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. BMJ 2016; 352: i1152.","DOI":"10.1136\/bmj.i1152"},{"key":"10.3238\/arztebl.m2023.0034_ref14","unstructured":"AGREE II Translations\u2014AGREE Enterprise website, German version. www.agreetrust.org\/wp-content\/uploads 2014\/03\/AGREE_II_German-Version.pdf (last accessed on 9 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref15","doi-asserted-by":"crossref","unstructured":"Schreier M: Qualitative content analysis in practice. Los Angeles: SAGE 2012.","DOI":"10.4135\/9781529682571"},{"key":"10.3238\/arztebl.m2023.0034_ref16","doi-asserted-by":"crossref","unstructured":"Bush SH, Grassau PA, Yarmo MN, Zhang T, Zinkie SJ, Pereira JL: The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice. BMC Palliat Care 2014; 13: 17.","DOI":"10.1186\/1472-684X-13-17"},{"key":"10.3238\/arztebl.m2023.0034_ref17","doi-asserted-by":"crossref","unstructured":"Klein C, Wittmann C, Wendt KN, Ostgathe C, Stiel S: Palliative Sedierung. Anaesthesist 2018; 67: 504\u201311.","DOI":"10.1007\/s00101-018-0451-4"},{"key":"10.3238\/arztebl.m2023.0034_ref18","doi-asserted-by":"crossref","unstructured":"Arantzamendi M, Belar A, Payne S, et al.: Clinical aspects of palliative sedation in prospective studies. A systematic review. J Pain Symptom Manage 2021; 61: 831\u201344. e10.","DOI":"10.1016\/j.jpainsymman.2020.09.022"},{"key":"10.3238\/arztebl.m2023.0034_ref19","doi-asserted-by":"crossref","unstructured":"Bozzaro C, Schildmann J: \u2018Suffering\u2019 in palliative sedation: conceptual analysis and implications for decision making in clinical practice. J Pain Symptom Manage 2018; 56: 288\u201394.","DOI":"10.1016\/j.jpainsymman.2018.04.003"},{"key":"10.3238\/arztebl.m2023.0034_ref20","doi-asserted-by":"crossref","unstructured":"Imai K, Morita T, Yokomichi N, et al.: Association of the RASS score with intensity of symptoms, discomfort, and communication capacity in terminally Ill cancer patients receiving palliative sedation: is RASS an appropriate outcome measure? Palliat Med Rep 2022; 3: 47\u201354.","DOI":"10.1089\/pmr.2021.0087"},{"key":"10.3238\/arztebl.m2023.0034_ref21","doi-asserted-by":"crossref","unstructured":"Belar A, Arantzamendi M, Payne S, et al.: How to measure the effects and potential adverse events of palliative sedation? An integrative review. Palliat Med 2021; 35: 295\u2013314.","DOI":"10.1177\/0269216320974264"},{"key":"10.3238\/arztebl.m2023.0034_ref22","doi-asserted-by":"crossref","unstructured":"Bodnar J: A review of agents for palliative sedation\/continuous deep sedation: pharmacology and practical applications. J Pain Palliat Care Pharmacother 2017; 31: 16\u201337.","DOI":"10.1080\/15360288.2017.1279502"},{"key":"10.3238\/arztebl.m2023.0034_ref23","doi-asserted-by":"crossref","unstructured":"Rietjens JAC, van der Heide A, Vrakking AM, Onwuteaka-Philipsen BD, van der Maas PJ, van der Wal G: Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands. Ann Intern Med 2004; 141: 178\u201385.","DOI":"10.7326\/0003-4819-141-3-200408030-00006"},{"key":"10.3238\/arztebl.m2023.0034_ref24","doi-asserted-by":"crossref","unstructured":"Schildmann E, Meesters S, Gr\u00fcne B, et al.: Sedatives and sedation at the end of life in the hospital\u2014a multicenter retrospective cohort study. Dtsch Arzteblatt Int 2022; 119: 373\u20139.","DOI":"10.3238\/arztebl.m2022.0194"},{"key":"10.3238\/arztebl.m2023.0034_ref25","doi-asserted-by":"crossref","unstructured":"Ciais JF, Jacquin P-H, Pradier C, Castelli-Prieto M, Baudin S, Tremellat F: Using sodium oxybate (gamma hydroxybutyric acid) for deep sedation at the end of life. J Palliat Med 2015; 18: 822.","DOI":"10.1089\/jpm.2015.0221"},{"key":"10.3238\/arztebl.m2023.0034_ref26","doi-asserted-by":"crossref","unstructured":"Hofherr ML, Abrahm JL, Rickerson E: Dexmedetomidine: a novel strategy for patients with intractable pain, opioid-induced hyperalgesia, or delirium at the end of life. J Palliat Med 2020; 23: 1515\u20137.","DOI":"10.1089\/jpm.2019.0427"},{"key":"10.3238\/arztebl.m2023.0034_ref27","doi-asserted-by":"crossref","unstructured":"Morita T, Kawahara T, Stone P, et al.: Intercountry and intracountry variations in opinions of palliative care specialist physicians in Germany, Italy, Japan and UK about continuous use of sedatives: an international cross-sectional survey. BMJ Open 2022; 12: e060489.","DOI":"10.1136\/bmjopen-2021-060489"},{"key":"10.3238\/arztebl.m2023.0034_ref28","unstructured":"The European Agency for the Evaluation of Medicinal Products: Committee for proprietary medicinal products (CPMP) Summary information on referral opinion following arbitration pursuant to article 30 of council directive 2001\/83\/EC for hypnovel and associated names. 2002. www.ema.europa.eu\/en\/documents\/referral\/summary-information-referral-opinion-following-arbitration-pursuant-article-30-council-directive\/83\/ec-hypnovel-associated-names-international-non-proprietary-name-inn-midazolam-background-infor_en.pdf (last accessed on 4 January 2023)."},{"key":"10.3238\/arztebl.m2023.0034_ref29","doi-asserted-by":"crossref","unstructured":"Hagemann V, Bausewein C, Remi C: Drug use beyond the licence in palliative care: A systematic review and narrative synthesis. Palliat Med 2019; 33: 650\u201362.","DOI":"10.1177\/0269216319840602"},{"key":"10.3238\/arztebl.m2023.0034_ref30","doi-asserted-by":"crossref","unstructured":"Kissane DW: The relief of existential suffering. Arch Intern Med 2012; 172: 1501\u20135.","DOI":"10.1001\/archinternmed.2012.3633"},{"key":"10.3238\/arztebl.m2023.0034_ref31","unstructured":"British Colombia Centre for Palliative Care: B.C. Inter-professional palliative symptom management guidelines. www.bc-cpc.ca\/cpc\/wp-content\/uploads\/2019\/06\/17-RefractorySymptomsAndPalliativeSedationColourPrint.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref32","unstructured":"Winnipeg Regional Health Authority (WRHA): Sedation for Palliative Purposes Guideline\u2014Evidence Informed Practice Tool. https:\/\/professionals.wrha.mb.ca\/old\/extranet\/eipt\/files\/EIPT-045.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref33","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS): Care Pathway Guide. How to implement continuous deep sedation until death? www.has-sante.fr\/upload\/docs\/application\/pdf\/2018\u201311\/care_pathway_guide_how_to_implement_continuous_deep_sedation_until_death.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref34","doi-asserted-by":"crossref","unstructured":"de Graeff A, Dean M: Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 2007; 10: 67\u201385.","DOI":"10.1089\/jpm.2006.0139"},{"key":"10.3238\/arztebl.m2023.0034_ref35","unstructured":"Edmonton Zone Palliative Care Program (EZPCP): Palliative Sedation Guideline. www.cspcp.ca\/wp-content\/uploads\/2017\/11\/Palliative-Sedation-Edmonton-Final-Dec-2015.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref36","unstructured":"Hospice & palliative care\u2014Federation of Massachusetts: Palliative Sedation Protocol. https:\/\/cdn.ymaws.com\/www.hospicefed.org\/resource\/resmgr\/hpcfm_pdf_doc\/pal_sed_protocol_2004.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref37","unstructured":"Fraser Health: Refractory Symptoms and Palliative Sedation Therapy Guideline. www.fraserhealth.ca\/-\/media\/Project\/FraserHealth\/FraserHealth\/Health-Professionals\/Professionals-Resources\/Hospice-palliative-care\/Sections-PDFs-for-FH-Aug31\/9524\u201328-FH---Sym_Guide-RefractoryPalliativeSedation.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref38","unstructured":"CHPC Program: The Champlain Region Palliative Sedation Therapy Clinical Practice and Medication Guidelines. www.champlainpalliative.ca\/wp-content\/uploads\/2018\/10\/PST-Guidelines-Regional-2018_ENG-final.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref39","unstructured":"The Norwegian Medical Association\u2014Den Norske Legeforening: Guidelines for palliative sedation at the end of life. www.legeforeningen.no\/contentassets\/cc8a35f6afd043c195ede88a15ae2960\/guidelines-for-palliative-sedation-at-the-end-of-life.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref40","unstructured":"palliative ch. Schweizerische Gesellschaft f\u00fcr Palliative Medizin, Pflege und Begleitung: BIGORIO 2005. Empfehlungen \u201ePalliative Sedation\u201c. www.palliative.ch\/public\/dokumente\/was_wir_tun\/angebote\/bigorio_best_practice\/BIGORIO_2005_-_Empfehlungen_Palliative_Sedation.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref41","unstructured":"Waterloo Wellington Interdisciplinary HPC Education Committee; PST Task Force: The Waterloo Wellington Palliative Sedation Protocol. http:\/\/hpcconnection.ca\/wp-content\/uploads\/2014\/07\/PalliativeSedationTherapyProtocolNovember2013.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref42","unstructured":"Human T, Johnston J, Land J, May W, Shipley S, Shobbrook C: The Mississauga Halton Palliative Sedation Therapy (PST). Sample policy. www.acclaimhealth.ca\/wp-content\/uploads\/2019\/01\/Palliative-Sedation-Therapy-Sample-Policy.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref43","doi-asserted-by":"crossref","unstructured":"Oechsle K, Radbruch L, Wolf C, Ostgathe C: SOP \u2013 Palliative Sedierung. Onkologe 2017; 23: 469\u201375.","DOI":"10.1007\/s00761-017-0240-8"},{"key":"10.3238\/arztebl.m2023.0034_ref44","unstructured":"Scotland N: Scottish Palliative Care Guidelines. Severe uncontrolled distress. www.palliativecareguidelines.scot.nhs.uk\/guidelines\/end-of-life-care\/severe-uncontrolled-distress.aspx (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref45","doi-asserted-by":"crossref","unstructured":"Rodriguez-Miranda R, Swetz KM, Hern\u00e1ndez-Ortiz A, Strand JJ, Lara-Solares A, Hern\u00e1ndez-Martinez EE: Palliative sedation: clinical practice challenges in Mexico and development of a national protocol for Mexico. Prog Palliat Care 2015; 23: 274\u201380.","DOI":"10.1179\/1743291X15Y.0000000001"},{"key":"10.3238\/arztebl.m2023.0034_ref46","unstructured":"Azzaria S, C\u00f4t\u00e9 A, Farley-Deschamps J, et al.: Palliative sedation at the end of life. www.cmq.org\/publications-pdf\/p-1-2016-08-29-en-sedation-palliative-fin-de-vie.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref47","unstructured":"Dans M, Kutner JS, Baker JN, et al.: NCCN Clinical Practice Guidelines in oncology: palliative care, Version 2.2019. www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref48","doi-asserted-by":"crossref","unstructured":"Kirk TW, Mahon MM, Palliative Sedation Task Force of the National H, Palliative Care Organization Ethics C: National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage 2010; 39: 914\u201323.","DOI":"10.1016\/j.jpainsymman.2010.01.009"},{"key":"10.3238\/arztebl.m2023.0034_ref49","unstructured":"(KNMG) RDMA: Guideline for Palliative Sedation. www.palliativedrugs.com\/download\/091110_KNMG_Guideline_for_Palliative_sedation_2009__2_%5B1%5D.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref50","unstructured":"Arrieta Ayestar\u00e1n M, Balagu\u00e9 Gea L, Ba\u00f1uelos Gordon A, et al.: Clinical Practice Guideline for Palliative Care. https:\/\/portal.guiasalud.es\/wp-content\/uploads\/2018\/12\/GPC_428_Palliative_Care_Osteba_compl_en_orig.pdf (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref51","doi-asserted-by":"crossref","unstructured":"Dean MM, Cellarius V, Henry B, Oneschuk D, Taskforce LCSOPCP: Framework for continuous palliative sedation therapy in Canada. J Palliat Med 2012; 15: 870\u20139.","DOI":"10.1089\/jpm.2011.0498"},{"key":"10.3238\/arztebl.m2023.0034_ref52","doi-asserted-by":"crossref","unstructured":"Cherny NI, Radbruch L, Board of the European Association for Palliative Care: European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009; 23: 581\u201393.","DOI":"10.1177\/0269216309107024"},{"key":"10.3238\/arztebl.m2023.0034_ref53","doi-asserted-by":"crossref","unstructured":"Cherny NI, Esmo Guidelines Working Group: ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol 2014; 25 Suppl 3: iii143\u201352.","DOI":"10.1093\/annonc\/mdu238"},{"key":"10.3238\/arztebl.m2023.0034_ref54","doi-asserted-by":"crossref","unstructured":"Neitzke G, Oehmichen F, Schliep H-J, W\u00f6rdehoff D: Sedierung am Lebensende. Onkologe 2010; 16: 789\u201394.","DOI":"10.1007\/s00761-010-1888-5"},{"key":"10.3238\/arztebl.m2023.0034_ref55","doi-asserted-by":"crossref","unstructured":"Imai K, Morita T, Akechi T, et al.: The principles of revised clinical guidelines about palliative sedation therapy of the Japanese Society for Palliative Medicine. J Palliat Med 2020; 23: 1184\u201390.","DOI":"10.1089\/jpm.2019.0626"},{"key":"10.3238\/arztebl.m2023.0034_ref56","doi-asserted-by":"crossref","unstructured":"Hawryluck LA, Harvey WR, Lemieux-Charles L, Singer PA: Consensus guidelines on analgesia and sedation in dying intensive care unit patients. BMC Med Ethics 2002; 3: E3.","DOI":"10.1186\/1472-6939-3-3"},{"key":"10.3238\/arztebl.m2023.0034_ref57","doi-asserted-by":"crossref","unstructured":"Weixler D, Roider-Schur S, Likar R, et al.: [Austrian guideline for palliative sedation therapy (long version): results of a Delphi process of the Austrian Palliative Society (OPG)]. Wien Med Wochenschr 2017; 167: 31\u201348.","DOI":"10.1007\/s10354-016-0533-3"},{"key":"10.3238\/arztebl.m2023.0034_ref58","unstructured":"Safe Care Victoria: palliative sedation therapy\u2014statewide guidance for Victoria. www.nla.gov.au\/nla.obj-2849065933 (last accessed on 10 August 2022)."},{"key":"10.3238\/arztebl.m2023.0034_ref59","unstructured":"Department of Health Western Australia: statewide guidance for the safe, effective and ethical use of palliative sedation. www.health.wa.gov.au\/-\/media\/Corp\/Documents\/Health-for\/End-of-Life\/End-of-life-choices\/Statewide-guidance-palliative-sedation.pdf (last accessed on 10 August 2022)."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T07:22:10Z","timestamp":1729149730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":59,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2023.0034","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]}}}